Skip to main content
SpringerLink
Log in

Vascular Effects of Somatostatin

  • Chapter
Somatostatin

Part of the book series: Endocrine Updates ((ENDO,volume 24))

  • 173 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alderton, F., Lauder, H., Feniuk, W., Fan, T. P., and Humphrey, P. P. (1998). Differential effects of somatostatin and angiopeptin on cell proliferation. Br J Pharmacol 124, 323–30.

    Article  CAS  PubMed  Google Scholar 

  2. Bass, R. T., Buckwalter, B. L., Patel, B. P., Pausch, M. H., Price, L. A., Strnad, J., Hadcock, J. R. (1996). Identification and characterization of novel somatostatin antagonists. Mol Pharmacol 50, 709–15.

    CAS  PubMed  Google Scholar 

  3. Bauters, C., de Groote, P., Adamantidis, M., Delcayre, C., Hamon, M., Lablanche, J. M., Bertrand, M. E., Dupuis, B., and Swynghedauw, B. (1992). Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty? Fur Heart J 13, 556–9.

    CAS  Google Scholar 

  4. Bauters, C., Van Belle, E., Wernert, N., Delcayre, C., Thomas, F., Dupuis, B., Lablanche, J. M., Bertrand, M. E., and Swynghedauw, B. (1994). Angiopeptin inhibits oncogene induction in rabbit aorta after balloon denudation. Circulation 89, 2327–31.

    CAS  PubMed  Google Scholar 

  5. Benditt, E. P., and Benditt, J. M. (1973). Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 70, 1753–6.

    CAS  PubMed  Google Scholar 

  6. Bruns, C., Shi, V., Hoyer, D., Schuurman, H., and Weckbecker, G. (2000). Somatostatin receptors and the potential use of Sandostatin to interfere with vascular remodelling. Eur J Endocrinol 143, S3–7.

    Article  CAS  PubMed  Google Scholar 

  7. Chen, J. C., Hsiang, Y. N., and Buchan, A. M. (1997). Somatostatin receptor expression in rat iliac arteries after balloon injury. J Invest Surg 10, 17–23.

    CAS  PubMed  Google Scholar 

  8. Chen, L., Hoeger, C., Rivier, J., Fitzpatrick, V. D., Vandlen, R. L., and Tashjian, A. H. (1999). Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin. Biochem Biophys Res Commun 258, 689–94.

    Article  CAS  PubMed  Google Scholar 

  9. Curtis, S. B., Chen, J. C., Winkelaar, G., Turnbull, R. G., Hewitt, J., Buchan, A. M., and Hsiang, Y. N. (2000a). Effect of endothelial and adventitial injury on somatostatin receptor expression. Surgery 127, 577–83.

    Article  CAS  PubMed  Google Scholar 

  10. Curtis, S. B., Hewitt, J., Yakubovitz, S., Anzarut, A., Hsiang, Y. N., and Buchan, A. M. (2000b). Somatostatin receptor subtype expression and function in human vascular tissue. Am J Physiol Heart Circ Physiol 278, H1815–22.

    CAS  PubMed  Google Scholar 

  11. Danesi, R., Agen, C., Benelli, U., Paolo, A. D., Nardini, D., Bocci, G., Basolo, F., Campagni, A., and Tacca, M. D. (1997). Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clin Cancer Res 3, 265–72.

    CAS  PubMed  Google Scholar 

  12. Du Toit, D., Aavik, E., Taskinen, E., Myburgh, E., Aaltola, E., Aimonen, M., Aavik, S., van Wyk, J., and Häyry, P. (2001). Structure of carotid artery in baboon and rat and differences in their response to endothelial denudation angioplasty. 2001 33, 63–78.

    Google Scholar 

  13. Emanuelsson, H., Beatt, K. J., Bagger, J. P., Balcon, R., Heikkila, J., Piessens, J., Schaeffer, M., Suryapranata, H., and Foegh, M. (1995). Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographie restenosis. European Angiopeptin Study Group. Circulation 91, 1689–96.

    CAS  PubMed  Google Scholar 

  14. Eriksen, U. H., Amtorp, O., Bagger, J. P., Emanuelsson, H., Foegh, M., Henningsen, P., Saunamaki, K., Schaeffer, M., Thayssen, P., and Orskov, H. (1995). Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Am Heart J 130, 1–8.

    Article  CAS  PubMed  Google Scholar 

  15. Ferns, G. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., and Ross, R. (1991). Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129–32.

    CAS  PubMed  Google Scholar 

  16. Foegh, M. L., Asotra, S., Conte, J. V., Howell, M., Kagan, E., Verma, K., and Ramwell, P. W. (1994). Early inhibition of myointimal proliferation by angiopeptin after balloon catheter injury in the rabbit. J Vasc Surg 19, 1084–91.

    CAS  PubMed  Google Scholar 

  17. Foegh, M. L., and Ramwell, P. W. (1995). Angiopeptin: experimental and clinical studies of inhibition of myointimal proliferation. Kidney Int Suppl 52, S18–22.

    Google Scholar 

  18. Frystyk, J., Skjaerbaek, C., Alexander, N., Emanuelsson, H., Suryapranata, H., Beyer, H., Foegh, M., and Orskov, H. (1996). Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty. Circulation 94, 2465–71.

    CAS  PubMed  Google Scholar 

  19. Grant, M. B., Wargovich, T. J., Ellis, E. A., Caballero, S., Mansour, M., and Pepine, C. J. (1994). Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? Circulation 89, 1511–7.

    CAS  PubMed  Google Scholar 

  20. Hayry, P., Isoniemi, H., Yilmaz, S., Mennander, A., Lemstrom, K., Raisanen-Sokolowski, A., Koskinen, P., Ustinov, J., Lautenschlager, I., and Taskinen, E. (1993a). Chronic allograft rejection. Immunol Rev 134, 33–81.

    CAS  PubMed  Google Scholar 

  21. Hayry, P., Myllarniemi, M., Aavik, E., Alatalo, S., Aho, P., Yilmaz, S., Raisanen-Sokolowski, A., Cozzone, G., Jameson, B. A., and Baserga, R. (1995). Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. Faseb J 9, 1336–44.

    CAS  PubMed  Google Scholar 

  22. Hayry, P., Raisanen, A., Ustinov, J., Mennander, A., and Paavonen, T. (1993b). Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. Faseb J 7, 1055–60.

    CAS  PubMed  Google Scholar 

  23. Hong, M. K., Kent, K. M., Tio, F. O., Foegh, M., Kornowski, R., Bramwell, O., Cathapermal, S. S., and Leon, M. B. (1997). Single-dose intramuscular administration of sustained-release Angiopeptin reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. Coron Artery Dis 8, 101–4.

    CAS  PubMed  Google Scholar 

  24. Howell, M., Orskov, H., Frystyk, J., Flyvbjerg, A., Gronbaek, H., and Foegh, M. (1994). Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study. Eur J Endocrinol 130, 422–5.

    CAS  PubMed  Google Scholar 

  25. Howell, M. H., Adams, M. M., Wolfe, M. S., Foegh, M. L., and Ramwell, P. W. (1993). Angiopeptin inhibition of myointimal hyperplasia after balloon angioplasty of large arteries in hypercholesterolaemic rabbits. Clin Sci (Colch) 85, 183–8.

    CAS  Google Scholar 

  26. Khare, S., Kumar, U., Sasi, R., Puebla, L., Calderon, L., Lemstrom, K., Hayry, P., and Patel, A. Y. (1999). Differential regulation of somatostatin receptor types 1–5 in rat aorta after angioplasty. Faseb J 13, 387–94.

    CAS  PubMed  Google Scholar 

  27. Kraiss, L. W., Raines, E. W., Wilcox, J. N., Seifert, R. A., Barrett, T. B., Kirkman, T. R., Hart, C. E., Bowen-Pope, D. F., Ross, R., and Clowes, A. W. (1993). Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J Clin Invest 92, 338–48.

    CAS  PubMed  Google Scholar 

  28. Lauder, H., Sellers, L. A., Fan, T. P., Feniuk, W., and Humphrey, P. P. (1997). Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells. Br J Pharmacol 122, 663–70.

    Article  CAS  PubMed  Google Scholar 

  29. Liapakis, G., Hoeger, C., Rivier, J., and Reisine, T. (1996). Development of a selective agonist at the somatostatin receptor subtype sstrl. J Pharmacol Exp Ther 276, 1089–94.

    CAS  PubMed  Google Scholar 

  30. Lundergan, C., Foegh, M. L., Vargas, R., Eufemio, M., Bormes, G. W., Kot, P. A., and Ramwell, P. W. (1989). Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034. Atherosclerosis 80, 49–55.

    Article  CAS  PubMed  Google Scholar 

  31. Mennander, A., Raisanen, A., Paavonen, T., and Hayry, P. (1993). Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis. Transplantation 55, 124–8.

    CAS  PubMed  Google Scholar 

  32. Miano, J. M., Tota, R. R., Vlasic, N., Danishefsky, K. J., and Stemerman, M. B. (1990). Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. Am J Pathol 137, 761–5.

    CAS  PubMed  Google Scholar 

  33. Myllarniemi, M., Calderon, L., Lemstrom, K., Buchdunger, E., and Hayry, P. (1997). Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. Faseb J 11, 1119–26.

    CAS  PubMed  Google Scholar 

  34. Patel, Y. C. (1999). Somatostatin and its receptor family. Front Neuroendocrinol 20, 157–98.

    CAS  PubMed  Google Scholar 

  35. Patel, Y. C., Greenwood, M. T., Panetta, R., Demchyshyn, L., Niznik, H., and Srikant, C. B. (1995). The somatostatin receptor family. Life Sci 57, 1249–65.

    Article  CAS  PubMed  Google Scholar 

  36. Patel, Y. C., and Srikant, C. B. (1994). Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1–5). Endocrinology 135, 2814–7.

    Article  CAS  PubMed  Google Scholar 

  37. Plissonnier, D., Nochy, D., Poncet, P., Mandet, C., Hinglais, N., Bariety, J., and Michel, J. B. (1995). Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 60, 414–24.

    CAS  PubMed  Google Scholar 

  38. Reisine, T., and Bell, G. I. (1995). Molecular biology of somatostatin receptors. Endocr Rev 16, 427–42.

    Article  CAS  PubMed  Google Scholar 

  39. Reubi, J. C., Horisberger, U., and Laissue, J. (1994a). High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int J Cancer 56, 681–8.

    CAS  PubMed  Google Scholar 

  40. Reubi, J. C., Mazzucchelli, L., and Laissue, J. A. (1994b). Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterology 106, 951–9.

    CAS  PubMed  Google Scholar 

  41. Reubi, J. C., Schaer, J. C., Laissue, J. A., and Waser, B. (1996a). Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 45, 39–41.

    Article  CAS  PubMed  Google Scholar 

  42. Reubi, J. C., Schaer, J. C., Wenger, S., Hoeger, C., Erchegyi, J., Waser, B., and Rivier, J. (2000). SST3-selective potent peptidic somatostatin receptor antagonists. Proc Natl Acad Sci USA 97, 13973–8.

    Article  CAS  PubMed  Google Scholar 

  43. Reubi, J. C., Waser, B., Laissue, J. A., and Gebbers, J. O. (1996b). Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Cancer Res 56, 1922–31.

    CAS  PubMed  Google Scholar 

  44. Rohrer, S. P., Birzin, E. T., Mosley, R. T., Berk, S. C., Hutchins, S. M., Shen, D. M., Xiong, Y., Hayes, E. C., Parmar, R. M., Foor, F., Mitra, S. W., Degrado, S. J., Shu, M., Klopp, J. M., Cai, S. J., Blake, A., Chan, W. W., Pasternak, A., Yang, L., Patchett, A. A., Smith, R. G., Chapman, K. T., and Schaeffer, J. M. (1998). Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282, 737–40.

    Article  CAS  PubMed  Google Scholar 

  45. Ross, R. (1999). Atherosclerosis-an inflammatory disease. N Engl J Med 340, 115–26.

    Article  CAS  PubMed  Google Scholar 

  46. Sakamoto, H., Sakamaki, T., Kanda, T., Ito, Y., Sumino, H., Masuda, H., Ohyama, Y., Ono, Z., Kurabayashi, M., Kobayashi, I., and Nagai, R. (1998). The somatostatin analog, octreotide, inhibits in vitro outgrowth of smooth muscle cells from canine coronary and carotid atherosclerotic plaque tissues. Res Commun Mol Pathol Pharmacol 101, 25–34.

    CAS  PubMed  Google Scholar 

  47. Santoian, E. D., Schneider, J. E., Gravanis, M. B., Foegh, M., Tarazona, N., Cipolla, G. D., and King, S. B. (1993). Angiopeptin inhibits intimai hyperplasia after angioplasty in porcine coronary arteries. Circulation 88, 11–4.

    CAS  PubMed  Google Scholar 

  48. Sarkar, R., Dickinson, C. J., and Stanley, J. C. (1999). Effects of somatostatin, somatostatin analogs, and endothelial cell somatostatin gene transfer on smooth muscle cell proliferation in vitro. J Vasc Surg 29, 685–93.

    Article  CAS  PubMed  Google Scholar 

  49. Schuurman, H. J., Beckmann, N., Briner, U., Bruns, C., Bruttel, K., Tanner, M., Tolcsvai, L., and Weckbecker, G. (1996). Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201–995. Transplant Proc 28, 3272–5.

    CAS  PubMed  Google Scholar 

  50. Schwartz, S. M., deBlois, D., and O’Brien, E. R. (1995). The intima. Soil for atherosclerosis and restenosis. Circ Res 77, 445–65.

    CAS  PubMed  Google Scholar 

  51. Schwartz, S. M., and Murry, C. E. (1998). Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med 49, 437–60.

    CAS  PubMed  Google Scholar 

  52. Sihvola, R., Koskinen, P., Myllarniemi, M., Loubtchenkov, M., Hayry, P., Buchdunger, E., and Lemstrom, K. (1999). Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor. Circulation 99, 2295–301.

    CAS  PubMed  Google Scholar 

  53. Smith, L. E., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., Schaeffer, J. M., and Senger, D. R. (1999). Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5, 1390–5.

    Article  CAS  PubMed  Google Scholar 

  54. Thyberg, J., Hedin, U., Sjolund, M., Palmberg, L., and Bottger, B. A. (1990). Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10, 966–90.

    CAS  PubMed  Google Scholar 

  55. Vargas, R., Wroblewska, B., Rego, A., Cathapermal, S., and Ramwell, P. W. (1997). Angiopeptin inhibits thymidine incorporation by expiants of porcine coronary arteries. J Cardiovasc Pharmacol 29, 278–83.

    Article  CAS  PubMed  Google Scholar 

  56. von Essen, R., Ostermaier, R., Grube, E., Maurer, W., Tebbe, U., Erbel, R., Roth, M., Oel, W., Brom, J., and Weidinger, G. (1997). Effects of octreotide treatment on restenosis after coronary angioplasty: results of the VERAS study. VErringerung der Restenoserate nach Angioplastie durch ein Somatostatin-analogon. Circulation 96, 1482–7.

    Google Scholar 

  57. Weckbecker, G., Pally, C., Raulf, F., Beckmann, N., Schuurman, J. H., Rudin, M., and Bruns, C. (1997). The somatostatin analog octreotide as potential treatment for re-stenosis and chronic rejection. Transplant Proc 29, 2599–600.

    Article  CAS  PubMed  Google Scholar 

  58. Yamashita, M., Dimayuga, P., Kaul, S., Shah, P. K., Regnstrom, J., Nilsson, J., and Cercek, B. (1999). Phosphatase activity in the arterial wall after balloon injury: effect of somatostatin analog octreotide. Lab Invest 79, 935–44.

    CAS  PubMed  Google Scholar 

  59. Yumi, K., Fagin, J. A., Yamashita, M., Fishbein, M. C., Shah, P. K., Kaul, S., Niu, W., Nilsson, J., and Cercek, B. (1997). Direct effects of somatostatin analog octreotide on insulin-like growth factor-I in the arterial wall. Lab Invest 76, 329–38.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rational Drug Design Programme, Biomedicum and Transplantation Laboratory, University of Helsinki, Finland

    Pekka Häyry & Einari Aavik

  2. Helsinki University Central Hospital, POBox 21, Haartmaninkatu 3, FIN 00014, Finland

    Pekka Häyry & Einari Aavik

  3. University of Helsinki, Finland

    Pekka Häyry & Einari Aavik

Authors
  1. Pekka Häyry
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Einari Aavik
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine, McGill University Heath Center, Montréal, Québec, Canada

    Coimbatore B. Srikant

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science + Business Media, Inc.

About this chapter

Cite this chapter

Häyry, P., Aavik, E. (2004). Vascular Effects of Somatostatin. In: Srikant, C.B. (eds) Somatostatin. Endocrine Updates, vol 24. Springer, Boston, MA. https://doi.org/10.1007/1-4020-8033-6_17

Download citation

  • DOI: https://doi.org/10.1007/1-4020-8033-6_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4020-7799-9

  • Online ISBN: 978-1-4020-8033-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation